JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

B7480 K 858

Summary: mitotic kinesin Eg5 inhibitor

Soluble in DMSO
B6234 2-Hydroxysaclofen

Summary: GABAB receptor antagonist

Soluble to 5 mM in H2O and to 100 mM in 1eq. NaOH
B6312 (+)-U-50488 hydrochloride

Summary: Selective κ-opioid agonist

<40.58 mg/mL
A4495 NCH 51

Summary: Histone deacetylase (HDAC) inhibitor
A4510 1,2,3,4,5,6-Hexabromocyclohexane

Summary: JAK2 tyrosine kinase inhibitor

insoluble in EtOH; insoluble in H2O; ≥8.22 mg/mL
A8255 Sunitinib malate
5 Citation

Target: VEGFR

Summary: VEGFR/PDGFRβ/ KIT/ FLT3/RET/CSF-1R inhibitor

≥26.65 mg/mL
A8322 Neratinib (HKI-272)
3 Citation

Target: EGFR

Summary: HER2/EGFR inhibitor,potent and irreversible

insoluble in H2O; ≥13.93 mg/mL
A8354 A66

Target: PI3K

Summary: P110α inhibitor

insoluble in H2O; ≥19.7 mg/mL
A8376 Bephenium Hydroxynaphthoate

Summary: Anthelmintic agent

insoluble in H2O; insoluble in EtOH; ≥20.85 mg/mL
A8639 Deferasirox
3 Citation

Summary: Oral iron chelator

insoluble in H2O; ≥37.28 mg/mL